Difference between revisions of "Chandimali Nisansala, et al. Cancer Gene Therapy (2018) cited as Ref 273 in DOI: 10.1038/s41392-020-0110-5 (Q9536)"
Jump to navigation
Jump to search
(Created claim: Fourth Author string (P152): Lee Jae Cheol, #quickstatements; #temporary_batch_1590155310798) |
(Created claim: Seventh Author string (P155): Kwon Taeho, #quickstatements; #temporary_batch_1590155721863) |
||
(One intermediate revision by the same user not shown) | |||
Property / Fifth Author string | |||
+ | Yu Dae-Yeul | ||
Property / Fifth Author string: Yu Dae-Yeul / rank | |||
+ | Normal rank | ||
Property / Sixth Author string | |||
+ | Jeong Dong Kee | ||
Property / Sixth Author string: Jeong Dong Kee / rank | |||
+ | Normal rank | ||
Property / Seventh Author string | |||
+ | Kwon Taeho | ||
Property / Seventh Author string: Kwon Taeho / rank | |||
+ | Normal rank |
Latest revision as of 13:55, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Chandimali Nisansala, et al. Cancer Gene Therapy (2018) cited as Ref 273 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Chandimali Nisansala
0 references
Huynh Do Luong
0 references
Zhang Jiao Jiao
0 references
10-Sep
0 references
2018
0 references
Cancer Gene Therapy
0 references
26
0 references
MicroRNA-122 negatively associates with peroxiredoxin-II expression in human gefitinib-resistant lung cancer stem cells (English)
0 references
292-304
0 references
Lee Jae Cheol
0 references
Yu Dae-Yeul
0 references
Jeong Dong Kee
0 references
Kwon Taeho
0 references